Application-validated cancer-research antibodies, each validated for two or more applications spanning Western blot, immunohistochemistry and immunofluorescence. Check each datasheet for the applications validated for your target. Save 15% with code ONCO15.
| Image | Product | Product Type | Application | Price | Status | ACTION |
|---|---|---|---|---|---|---|
|
Target: Gnao1a | Antibodies, Primary Antibodies | Western Blot, Immunohistochemistry, Immunofluorescence |
$555.17
Regular price
$555.17
|
In Stock at Manufacturer | |
|
Target: ZMYND8 | Antibodies, Primary Antibodies | Western Blot, Immunohistochemistry, Immunofluorescence, Flow Cytometry, ELISA |
$462.47
Regular price
$462.47
|
In Stock at Manufacturer | |
|
Polyclonal Antibody | Western Blot, Immunohistochemistry, Immunofluorescence, Immunoprecipitation |
From $265.74
Regular price
From $265.74
|
In Stock at Manufacturer |
Every antibody here is validated for multiple cancer-research applications — two or more of Western blot, immunohistochemistry and immunofluorescence. Check each datasheet for the applications and images validated for your specific target. Use code ONCO15 for 15% off cancer antibodies.
Two antibodies to the same target are not interchangeable. The deciding factor is the evidence behind the listing — in which applications, species, and with what images. This collection sets the bar at multi-application validation: every antibody is validated in two or more of WB, IHC and IF.
| Decision dimension | Multi-application validated (this collection) | Single-application | Catalog / RUO-only |
|---|---|---|---|
| Validation evidence | Two or more of WB / IHC / IF, with datasheet data | One application (often WB only) | Specification sheet; little or no application data |
| Applications confirmed | 2+ (across lysate, tissue and/or cells) | 1 | 0–1, frequently predicted |
| Reproducibility risk | Lower — cross-application concordance | Moderate — format-dependent | Higher — unverified |
| Best for | Publication-grade tumor work across methods | A single, well-defined assay | Early screening on a budget |
| Watch-outs | Confirm the validated applications, species and clone for your model | May not transfer to IHC/IF | Plan to validate in-house first |
How to read this: if your project spans lysate, tissue and cells — or is headed for publication — start here, where every antibody is validated in two or more of these applications. Confirm on the datasheet which applications are validated for your target. If you only need one assay, the broader Cancer Antibodies catalog has more single-application options; for non-cancer targets browse all Antibodies. Validation is per-clone and per-lot — always check the datasheet image for your specific application and species.
Please use this form for bulk quantity requests or customized products.
